Explore <strong>Dydrogesterone</strong>, a synthetic progestogen, used to treat various gynecological conditions like endometriosis and menstrual disorders, helping restore hormonal balance.
Browse our catalog for available pharmaceutical products and competitive pricing.
Dydrogesterone is a synthetic progestogen, a type of hormone that mimics the action of naturally occurring progesterone in the body. Unlike some other synthetic progestogens, Dydrogesterone is structurally similar to natural progesterone, which contributes to its specific pharmacological profile. It is primarily used in hormone replacement therapy and for the treatment of various gynecological disorders where progesterone deficiency is a contributing factor. Its unique molecular structure allows it to bind selectively to progesterone receptors, leading to its therapeutic effects with a generally favorable side effect profile.
The development of Dydrogesterone dates back to the mid-20th century, representing a significant advancement in synthetic progestogen research. Its introduction provided a valuable tool for managing a range of conditions, offering a progestogenic effect without significant androgenic, estrogenic, glucocorticoid, or mineralocorticoid activity, which can be associated with some other synthetic progestins. This selectivity makes Dydrogesterone a preferred choice for specific clinical applications, minimizing unwanted hormonal side effects.
Classified as a progestogen, Dydrogesterone falls under the ATC code G03DB01 (Dydrogesterone) within the broader category of G03D (Progestogens). Its primary role is to regulate the menstrual cycle, support pregnancy, and counteract the proliferative effects of estrogen on the endometrium. This makes it indispensable in treating conditions such as irregular menstruation, endometriosis, dysfunctional uterine bleeding, and in fertility treatments to support the luteal phase, thereby playing a crucial role in women's reproductive health.
The therapeutic efficacy of Dydrogesterone stems from its selective agonistic activity on progesterone receptors. Upon oral administration, Dydrogesterone is rapidly absorbed and converted into its primary active metabolite, 20α-dihydrodydrogesterone (DHD). Both Dydrogesterone and DHD bind to progesterone receptors located in target tissues, including the uterus, breast, hypothalamus, and pituitary gland. This binding initiates a cascade of intracellular events that mimic the actions of endogenous progesterone, influencing gene expression and cellular function.
Crucially, Dydrogesterone exhibits a high degree of selectivity for progesterone receptors, meaning it does not significantly interact with estrogen, androgen, glucocorticoid, or mineralocorticoid receptors. This selective binding minimizes potential off-target hormonal effects often seen with less selective progestins. In the endometrium, Dydrogesterone induces a full secretory transformation in estrogen-primed tissue, which is essential for successful embryo implantation and for preventing endometrial hyperplasia in women undergoing estrogen replacement therapy. It also suppresses gonadotropin release, thereby inhibiting ovulation, and affects cervical mucus viscosity and fallopian tube motility, contributing to its contraceptive and therapeutic effects.
Dydrogesterone is a versatile synthetic progestogen with a wide range of medical applications, primarily focused on gynecological and reproductive health. Its ability to mimic natural progesterone makes it invaluable in managing conditions associated with progesterone deficiency or imbalance, supporting the menstrual cycle, and assisting in fertility treatments. It is recognized for its efficacy and favorable tolerability profile in these specific therapeutic areas.
The dosage and administration of Dydrogesterone vary significantly depending on the specific indication, the patient's individual response, and the clinical judgment of the prescribing physician. It is typically administered orally, and adherence to the prescribed regimen is crucial for optimal therapeutic outcomes. The duration of treatment can range from a few days to several months or even longer, particularly in chronic conditions or during pregnancy support.
| Indication | Typical Dose | Frequency | Route |
|---|---|---|---|
| Endometriosis | 10 mg | 2-3 times daily (continuously or cyclically) | Oral |
| Dysfunctional Uterine Bleeding | 10 mg | Once or twice daily for 5-7 days | Oral |
| Threatened Miscarriage | 10 mg | Initially 40 mg, then 10 mg every 8 hours | Oral |
| Luteal Phase Support (ART) | 10-20 mg | Once daily, starting on day of egg retrieval/transfer | Oral |
Important: Always follow your prescriber instructions. Dosages vary by weight, age, and condition, and may be adjusted based on clinical response and monitoring. Do not self-medicate or alter your prescribed dosage of Dydrogesterone.
While Dydrogesterone is generally well-tolerated, like all medications, it can cause side effects. These are usually mild and transient, but it is important to be aware of them and to report any concerning symptoms to your healthcare provider. The incidence and severity of side effects can vary among individuals.
Drug interactions can alter the effectiveness of Dydrogesterone or increase the risk of side effects. It is crucial to inform your healthcare provider about all medications you are currently taking, including prescription drugs, over-the-counter medicines, herbal supplements, and recreational drugs, to avoid potential interactions. Dydrogesterone is primarily metabolized by cytochrome P450 enzymes, particularly CYP3A4, which makes it susceptible to interactions with drugs that induce or inhibit this enzyme.
Dydrogesterone is not suitable for everyone. Certain medical conditions or circumstances contraindicate its use due to the potential for harm or exacerbation of existing health issues. Always discuss your complete medical history with your doctor before starting treatment with Dydrogesterone.
Medical Disclaimer: This information is for educational purposes only. Always consult a qualified healthcare professional before starting, stopping, or changing any medication.
The safety of long-term use of Dydrogesterone depends on the specific indication and individual patient factors. For conditions like endometriosis or in hormone replacement therapy, it may be prescribed for extended periods under medical supervision. Regular medical check-ups, including gynecological examinations and monitoring for potential side effects, are essential to ensure its continued safety and efficacy during prolonged treatment. Your doctor will weigh the benefits against any potential risks for your specific situation.
Dydrogesterone can generally be taken with or without food. However, taking it with food might help to reduce gastrointestinal side effects such as nausea or stomach upset, if experienced. It is always best to follow the specific instructions provided by your doctor or pharmacist regarding the timing and method of administration to ensure optimal absorption and effectiveness of the medication.
If you miss a dose of Dydrogesterone, take it as soon as you remember, unless it is almost time for your next scheduled dose. In that case, skip the missed dose and continue with your regular dosing schedule. Do not take a double dose to make up for a missed one, as this can increase the risk of side effects. If you are unsure or frequently miss doses, consult your healthcare provider for advice.
Dydrogesterone is a prescription medication and cannot be purchased without a valid prescription from a licensed healthcare professional. It should be obtained only through legitimate and licensed pharmacies or medical suppliers. Attempting to buy Dydrogesterone from unregulated sources, such as unauthorized online vendors or black markets, carries significant risks, including receiving counterfeit, substandard, or inappropriate medication that could be harmful to your health. Always prioritize your safety by acquiring medications through official medical channels.